Matches in Nanopublications for { ?s ?p "[In this study, HepG2 cells were used to investigate the role of HSD17B4 in the proliferation of liver cancer cells treated with the NF-?B activator, tumor necrosis factor-alpha (TNF-?), with the inhibitor of NF-?B activation, pyrrolidinedithiocarbamate (PDTC), or with a related specific siRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[In this study, HepG2 cells were used to investigate the role of HSD17B4 in the proliferation of liver cancer cells treated with the NF-?B activator, tumor necrosis factor-alpha (TNF-?), with the inhibitor of NF-?B activation, pyrrolidinedithiocarbamate (PDTC), or with a related specific siRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In this study, HepG2 cells were used to investigate the role of HSD17B4 in the proliferation of liver cancer cells treated with the NF-?B activator, tumor necrosis factor-alpha (TNF-?), with the inhibitor of NF-?B activation, pyrrolidinedithiocarbamate (PDTC), or with a related specific siRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_assertion description "[In this study, HepG2 cells were used to investigate the role of HSD17B4 in the proliferation of liver cancer cells treated with the NF-?B activator, tumor necrosis factor-alpha (TNF-?), with the inhibitor of NF-?B activation, pyrrolidinedithiocarbamate (PDTC), or with a related specific siRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242308.RAdpSKVqxI1OiUMy3EE5lsrxDUXOSsm1iyqrnrOOhLpww130_provenance.
- NP1242307.RA93QNrVae7nZNhwDZv_L7_hEDWueFjQ6n9fBvtJ6gsZk130_assertion description "[In this study, HepG2 cells were used to investigate the role of HSD17B4 in the proliferation of liver cancer cells treated with the NF-?B activator, tumor necrosis factor-alpha (TNF-?), with the inhibitor of NF-?B activation, pyrrolidinedithiocarbamate (PDTC), or with a related specific siRNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1242307.RA93QNrVae7nZNhwDZv_L7_hEDWueFjQ6n9fBvtJ6gsZk130_provenance.